Alzheimer’s disease is a devastating neurodegenerative condition that affects many of our elderly in the United States and across the world. While, there is no cure for Alzheimer’s, there are several drugs available that can treat the symptoms and slow down the progress if it is caught in time.
That is until now…
The Wisconsin Alzheimer’s Disease Research Center in Madison is reporting that they are working on a new drug that may actually cure Alzheimer’s disease. The drug, known as T-817MA, is the first to actually treat the disease instead of the symptom.
“I think it could be a very major breakthrough,” says Dr. Sanjay Asthana. “This medication will stop any damage to the brain. The hope is that the patient will likely stay very stable over time.”
“This drug really helps in the survival of the brain cells and prevents them from getting damaged due to Alzheimer’s Disease,” Asthana says.
The drug has the potential to slow down the disease and stop it before it starts. Known as “The NOBLE Study”, it will be tested on 450 patients, nationwide, over the next three years at dozens of clinics, including the VA Hospital in Madison. The research team consists of more than 20 people and they are currently looking for patients to participate in the clinical studies.
“The trials are free to the patient. The drug has shown the potential to slow down the progress of the disease and possibly stop it altogether,” Asthana explains.
Anyone who is interested in participating in the study can call (608)-263-2582 for more information.
You can also visit the Wisconsin Alzheimer’s Disease Research Center website at adrc.wisc.edu or email them at firstname.lastname@example.org
For more information on this study or Alzheimer’s disease, please contact Kabb Law at 216-991-KABB (5222).